On October 1, 2020, the isatuximab-irfc (Sarclisa®, Sanofi Genzyme) healthcare common procedure coding system (HCPCS) level II J code (J9227) will be effective.
Read the one pager.
Posted 9/18/2020
Understanding both the benefits to be had from offering BsAb therapy to its community and the scope of this undertaking, Vanderbilt-Ingram Cancer Center took a novel approach with its APP-led BsAb step-up dosing clinic, which won the program a 2026 ACCC Innovator Award.
